• Теги
    • избранные теги
    • Компании855
      • Показать ещё
      Разное212
      • Показать ещё
      Страны / Регионы218
      • Показать ещё
      Международные организации24
      • Показать ещё
      Формат15
      Люди20
      • Показать ещё
      Показатели27
      • Показать ещё
      Издания13
      • Показать ещё
Novo Nordisk
13 января, 22:20

Cory Booker Chooses Wall Street Over Main Street

Oh, Senator Cory Booker. I was so looking forward to 2020, in hopes that you would run for president. But now I fear that your 2020 campaign is doomed before it even starts. You are a talented and thoughtful senator. Your leadership on the issue of criminal justice reform made you a rock star in my world. But now you’ve revealed yourself to be just another Wall Street Democrat, out-of-touch with the concerns of Main Street America, just like your party’s doomed 2016 nominee, Hillary “I’m Not The Bad Man Who Says Bad Things” Clinton. This week, the Senate got on the fast track to its first agenda item in erasing any evidence there was ever a black president - the repeal of Obamacare. Democrats offered amendment after amendment to try and save any sliver of it they could. One by one, those amendments all failed. But one amendment would have passed. Senators Bernie “Maybe Next Time You’ll Pay Attention To Huge Rallies” Sanders and Amy “The Non-Franken Minnesotan” Klobuchar put forth an amendment to allow the importation of prescription drugs from Canada, in order to greatly reduce medication costs for Americans. Twelve Republicans voted for it, guaranteeing its passage if Democrats supported it. Senate Amendment 178: The Chairman of the Committee on the Budget of the Senate may revise the allocations of a committee or committees, aggregates, and other appropriate levels in this resolution for one or more bills, joint resolutions, amendments, amendments between the Houses, motions, or conference reports relating to lowering prescription drug prices, including through the importation of safe and affordable prescription drugs from Canada by American pharmacists, wholesalers, and individuals with a valid prescription from a provider licensed to practice in the United States, by the amounts provided in such legislation for those purposes, provided that such legislation would not increase the deficit over either the period of the total of fiscal years 2017 through 2021 or the period of the total of fiscal years 2017 through 2026. But some in the Democratic Party learned nothing from their electoral drubbing* and put the concerns of average Americans below the concerns of corporate campaign contributors. Given that choice, Senator Booker, you chose Wall Street over Main Street. You joined with Democratic senators Bennet (D-CO), Cantwell (D-WA), Carper (D-DE), Casey (D-PA), Coons (D-DE), Donnelly (D-IN), Heinrich (D-NM), Heitkamp (D-ND), Menendez (D-NJ), Murray (D-WA), Tester (D-MT), and Warner (D-VA) in ensuring Americans continue to pay the highest price for prescriptions in the world. Also, Senator Feinstein (D-CA) couldn’t be bothered to vote at all. You and some of the other Big Pharma Democrats are trying to sell us the excuse that you’re worried about the safety of imported drugs. We’re not stupid. We know that people have been illegally importing prescription drugs from Canada for years now; we saw Senator Bernie “Who’s The Unelectable One Now?” Sanders take busloads of seniors over the northern border to get cheap prescriptions filled and it didn’t seem to kill them off. We’ve got friends in Canada who use those drugs and their country hasn’t had any tainted prescription scandals. We know it is no coincidence that both New Jersey Democratic senators** voted against this amendment and there are 249 pharmaceutical companies headquartered in New Jersey. We know it is no coincidence that Merck & Co, Johnson & Johnson, Novo Nordisk, Novartis, and other health care industries have lined your pockets to the tune of over $945,474. We know it is no coincidence that your “worried about safety” excuse is the exact talking point promulgated by big pharma - literally PhRMA, the Pharmaceutical Research and Manufacturers Association: “The importation of unapproved and potentially counterfeit medicines into the United States jeopardizes our secure medicine system and presents a serious risk to public health,” a PhRMA spokesperson told HuffPost in a statement. “Guaranteeing patient safety is crucial, and we must have policies that ensure patients safely have access to the medicines they need.” The parents of a desperately ill child or the seniors whose lives depend on prescription medication aren’t worried that the pills they need are unsafe if they can’t afford to buy them in the first place. And Senator Booker, you knew full well that amendment only began the process of importing Canadian drugs, allowing Congress to further pass laws designed to ensure their safety. It’s not as if your YEA vote would have put Canadian pills in pharmacies tomorrow. Cory Booker, you have betrayed us. If you’re the Democrats’ hope for 2020, we all better prepare for eight years of a Trump Administration. ――   * And don’t you start in on the “3 million more votes” or “James Comey” or “Russian hacking” excuses. Hillary Clinton was running against an incompetent profane idiot narcissist on the heels of her party’s popular two-term incumbent who left her years of job growth, a surging stock market, increased health insurance coverage, reduced foreign occupations, and a dead Osama bin Laden to run on; she should have won by a landslide. Two-time Obama voters in the Rust Belt voted for Trump because they believed Hillary and the Democrats were oblivious to Main Street problems. Cory Booker and the Democratic Big Pharma caucus just proved them right. ** You’re not off the hook, either, Democratic Senators Murray ($2,732,660) and Cantwell ($1,096,243) from Washington (120 companies), Democratic Senators Carper ($1,136,706) and Coons ($620,668) from Delaware (15 companies, including Astra-Zeneca), and Democratic Senator Casey ($2,187,181) from Pennsylvania (211 companies, including GlaxoSmithKline and Johnson & Johnson). Y’all just aren’t running for president in 2020. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

13 января, 10:32

Фондовые индексы Европы снизились в четверг, но британский FTSE снова вырос

Европейские фондовые индексы завершили в минусе торги в четверг вслед за котировками акций автомобилестроительных и фармацевтических компаний, однако британский индикатор вновь увеличился и обновил рекорд.

12 января, 13:17

Европейские фондовые индексы снижаются в четверг, дешевеют акции ритейлеров

Европейские фондовые индексы снижаются в четверг вслед за котировками акций фармацевтических компаний.

Выбор редакции
12 января, 12:05

Novo Nordisk down 4.7% following news of lawsuit

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

11 января, 16:27

Novo Nordisk (NVO) Fiasp Gets EU Nod for Diabetes in Adults

Novo Nordisk (NVO) announced that its fast-acting insulin aspart, Fiasp, has been approved in the EU for the treatment of diabetes in adults.

05 января, 16:06

Lilly Jardiance Family Diabetes Drugs' Label to be Updated

Eli Lilly & Company (LLY) recently announced that the FDA has approved the inclusion of data from the EMPA-REG OUTCOME study on the labels of three type 2 diabetes medicines belonging to the Jardiance family ??? Synjardy, Synjardy XR and Glyxambi.

04 января, 20:20

Stock Research Reports for Comcast, Amgen & General Mills

Stock Research Reports for Comcast, Amgen & General Mills

04 января, 00:20

VIVUS (VVUS): Will Qsymia & Stendra Sales Improve in 2017?

On Jan 3, we issued an updated report on VIVUS, Inc. (VVUS).

03 января, 09:59

Robust Design Compliance as a strong competitive advantage

Co-written by Anna Lykke Lundholm-Andersen Compliance with various standards in product development often amounts to intense requirements within both R&D and production. Implementing an optimized design method such as the one advanced by Danish engineering consultancy company, Valcon Design, can significantly impact these challenges. Applying the Pareto 80/20 optimization rule to compliance, stating that 80% of one's results stems from 20% of one's effort, allows Robust Design to focus and increase the efficiency of procedures and to provide a competitive advantage. The trick with Robust Design is to eliminate the costly iterations and thus make designs right the first time. Robust Design relies on the philosophy that optimization in design is the next evolutionary step within engineering. The new design (coined Six Theta® Design by Valcon Design) thus represents a major opportunity for industrial development companies to shorten the ramp-up time for R&D processes and create a more robust end-result by simplifying the designs, cutting off superfluous interfaces making the designs more tolerant towards over-constraints which usually force tighter tolerances that are expensive to achieve. According to Niels-Aage Hansen, Chief Engineer of Novo Nordisk, the definition of Robust Design is: "A design that is less sensitive to variation and that will therefore sustainably meet requirements. Working with Robust Design means optimizing the design by systematic assessment and calculations as opposed to the use of trial and error. The robustness KPIs are leading indicators for quality of the mechanical design." The industry has perfected standardized products via Six Sigma®. However, Robust Design represents a blind spot in the industry and by making initial rough calculations on designs one can reach a supreme level of predictability. This saves precious time on detailing the designing, testing and prototyping necessary to reach Sig Sigma® compliance. Thus, it is a far more efficient process for allocating the same resources to innovation and meeting the high demands of punctuality when releasing new products. During the one and a half year required for implementation, Novo Nordisk was shown to be the type of organization ready for the necessary change in mindset that Valcon Design wished to implement. Valcon Design wanted a change of culture in design methods and as the design changes were implemented throughout the organization from R&D to QA, these methods succeeded. The new design paradigm meant that engineers had to adapt to making rough calculations on designs before settling on one in particular. They also had to identify and eliminate 'design-waste', and production had to adjust to the new design. "To support and decide that Robust Design should be mandatory in Novo Nordisk Device R&D required an intense dialogue and training of our highly skilled engineers and production employees. The evident benefits of the Robust Design process carry a huge benefit for our manufacturing economy and improved patient experience long term." - Kenneth Strømdahl, senior vice president of Device R&D, Novo Nordisk. When analyzing non-compliant products, Valcon Design's engineers usually find approximately fifteen weaknesses per component in any given design. By being proactive about implementing the new design, companies can focus their resources on generating new products that put them in a superior competitive position instead of wrestling with complications from high tolerance demanding designs that have already exceeded budgets. With globalization comes an increased demand for ambidexterity and agility, industry is forced to seek out new paths in order to uphold a competitive position in an environment that keeps pressuring prices down. One is to lower the costs by moving production to low-cost countries whilst meeting the high compliance demands in production. Another is to simply be smarter about our designs, Special thanks to Anna Lykke Lundholm-Andersen for researching and co-writing this article -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

28 декабря 2016, 14:29

Основные фондовые индексы Европы торгуются без единой динамики

Европейские фондовые индексы торгуются разнонаправлено, но остаются вблизи уровня открытия, что связано с низкой торговою активностью в преддверии праздников. Рост акций горнодобывающих и нефтегазовых компаний компенсирует небольшой спад в других секторах. Британский индекс FTSE 100, который возобновил торги после четырехдневного перерыва, умеренно вырос, чему способствует повышение котировок акций горнодобывающих компаний. Определенное влияние также оказали статданные по Британии. Ассоциация британских банкиров (BBA) сообщила, что количество ипотечных кредитов, утвержденных британскими банками, немного снизилось в прошлом месяце после того, как достигло пятимесячного максимума в октябре. Вместе с тем, потребительское кредитование продолжило повышаться высокими темпами. Согласно отчету, банки одобрили 40,659 ипотечных кредитов в ноябре по сравнению с 40,835 в октябре (пересмотрено с 40 850). В годовом выражении, число одобренных ипотечных кредитов сократилось на 9 процентов. Кредитование с помощью кредитных карт увеличилось на 231 млн. фунтов стерлингов, зафиксировав самый большой рост за последние четыре месяца. Кроме того, в BBA указали на сильное увеличение депозитов на личных банковских счетах, на 1,2 млрд. фунтов за месяц. "Такой рост вкладов физических лиц может предположить, что потребители ищут возможности, чтобы увеличить свои денежные резервы в преддверии возможных экономических неопределенностей, таких как ожидания снижения темпов роста заработной платы", - говорит Ребекка Хардинг, главный экономист BBA. Сводный индекс крупнейших предприятий региона Stoxx Europe Index 600 торгуется с повышением на 0,07 процента. Датчик акций основных ресурсов, который вырос более чем на 2 процента, демонстрирует наибольшее повышение среди 19 отраслевых групп Stoxx 600. Капитализация горнодобывающего гиганта BHP Billiton и Anglo American увеличилась более чем на 4 процента. Инвесторы также пристально следят за ситуацией в банковском секторе, учитывая беспокойство по поводу состояния европейской банковской системы. Датчик акций банков демонстрирует снижение на 0,16 процента. Тем временем, котировки Deutsche Bank и Credit Suisse обвалились на 1,7 процента и 0,4 процента соответственно. Стоимость Bovis Homes снизилась на 4,4 процента после предупреждений о возможном падении прибыли и ухудшении оценок по продажам домов в 2016 году. Цена бумаг Volkswagen выросла на 0,5 процента на фоне сообщений о приобретении канадского приложения PayByPhone для оплаты парковки. Однако, сумма сделки остается неизвестной. Капитализация Sanofi снизилась на 0,1 процента после того, как фармацевтическая компания заявила, что подала в суд на датского конкурента Novo Nordisk. На текущий момент FTSE 100 +25.05 7093.22 +0.35% DAX -1.96 11470.28 -0.02% CAC 40 -2.95 4845.33 -0.06% Информационно-аналитический отдел TeleTradeИсточник: FxTeam

28 декабря 2016, 14:29

Основные фондовые индексы Европы торгуются без единой динамики

Европейские фондовые индексы торгуются разнонаправлено, но остаются вблизи уровня открытия, что связано с низкой торговою активностью в преддверии праздников. Рост акций горнодобывающих и нефтегазовых компаний компенсирует небольшой спад в других секторах. Британский индекс FTSE 100, который возобновил торги после четырехдневного перерыва, умеренно вырос, чему способствует повышение котировок акций горнодобывающих компаний. Определенное влияние также оказали статданные по Британии. Ассоциация британских банкиров (BBA) сообщила, что количество ипотечных кредитов, утвержденных британскими банками, немного снизилось в прошлом месяце после того, как достигло пятимесячного максимума в октябре. Вместе с тем, потребительское кредитование продолжило повышаться высокими темпами. Согласно отчету, банки одобрили 40,659 ипотечных кредитов в ноябре по сравнению с 40,835 в октябре (пересмотрено с 40 850). В годовом выражении, число одобренных ипотечных кредитов сократилось на 9 процентов. Кредитование с помощью кредитных карт увеличилось на 231 млн. фунтов стерлингов, зафиксировав самый большой рост за последние четыре месяца. Кроме того, в BBA указали на сильное увеличение депозитов на личных банковских счетах, на 1,2 млрд. фунтов за месяц. "Такой рост вкладов физических лиц может предположить, что потребители ищут возможности, чтобы увеличить свои денежные резервы в преддверии возможных экономических неопределенностей, таких как ожидания снижения темпов роста заработной платы", - говорит Ребекка Хардинг, главный экономист BBA. Сводный индекс крупнейших предприятий региона Stoxx Europe Index 600 торгуется с повышением на 0,07 процента. Датчик акций основных ресурсов, который вырос более чем на 2 процента, демонстрирует наибольшее повышение среди 19 отраслевых групп Stoxx 600. Капитализация горнодобывающего гиганта BHP Billiton и Anglo American увеличилась более чем на 4 процента. Инвесторы также пристально следят за ситуацией в банковском секторе, учитывая беспокойство по поводу состояния европейской банковской системы. Датчик акций банков демонстрирует снижение на 0,16 процента. Тем временем, котировки Deutsche Bank и Credit Suisse обвалились на 1,7 процента и 0,4 процента соответственно. Стоимость Bovis Homes снизилась на 4,4 процента после предупреждений о возможном падении прибыли и ухудшении оценок по продажам домов в 2016 году. Цена бумаг Volkswagen выросла на 0,5 процента на фоне сообщений о приобретении канадского приложения PayByPhone для оплаты парковки. Однако, сумма сделки остается неизвестной. Капитализация Sanofi снизилась на 0,1 процента после того, как фармацевтическая компания заявила, что подала в суд на датского конкурента Novo Nordisk. На текущий момент FTSE 100 +25.05 7093.22 +0.35% DAX -1.96 11470.28 -0.02% CAC 40 -2.95 4845.33 -0.06% Информационно-аналитический отдел TeleTradeИсточник: FxTeam

Выбор редакции
27 декабря 2016, 18:52

New Strong Sell Stocks for December 27th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

23 декабря 2016, 01:07

Why It Pays To Find Your Company's Global Purpose

Co-authored by Paula Miquelis, Senior Project Manager, & Laura Allen, Founder, at Gone Adventurin. Every company's supply chain ends with a human being's life. And the people who need a company's services, use its products, or are on its payroll rely on one planet. And here is something most can agree on: Our planet is suffering. The list of societal and environmental problems seems endless. Hunger, poverty, inequality, war, water scarcity, climate change, and so on. Within these wicked problems may lie a company's most compelling and profitable driver: A global purpose to save the world. The world's companies will play a vital role in solving these complex human problems. Businesses have the collective ability to reach billions of people and exert tremendous spending power. This power positions them to be key players in restoring our planet. Embracing this higher purpose is not only good for the planet, it may be an essential business strategy for the modern organization. President & CEO of Novo Nordisk, Lars Rebien Sørensen, warns, "In the long term, social and environmental issues become financial issues." Embracing a long-view and awakening a compelling global purpose now may sustain the life of the business itself. What is purpose? Purpose has become the latest business buzzword. So it is important to be clear on its enduring and powerful definition. Quite simply, purpose is "...the reason for which something exists." Your company's purpose is not a mission statement, a tactic, or a goal. It is quite literally a company's guiding reason for existence on the planet. The company's job is to justify that reason every day. A reason for existence doesn't fade with time or change with market conditions. Purpose taps into people's psychological desire to make the world better and to do good. Purpose permeates every behavior and thought in a company. And a good purpose is a reason worth committing to that inspires service to the greater good. A company's purpose has to be more important than the company itself. And when companies embrace a guiding global purpose that seeks to better the world beyond their financial returns, success follows. Why? Because a global purpose drives the people who drive the profit. Why a Global Purpose Drives Profit Having a global purpose is good business. In Built to Last, Jim Collins found that companies with a higher purpose outperform the market by an average of six-to-one. Those companies also experienced growth rates three times that of their competitors. The economic power of a higher purpose can be found when studying a company like Unilever. Unilever's brands with a clear and communicated societal purpose - like Comfort, Dove, and Ben & Jerry's - are growing faster than the rest of the portfolio. Unilever CEO Paul Polman said, "Our sustainable living brands are growing 30% faster than the rest of our business and delivered nearly half our total growth in 2015, our latest figures show." Former Procter & Gamble Marketing Director Jim Stengel found similar results in his study on the relationship between a higher purpose and market growth. Stengel's research demonstrated that purpose-driven brands perform ten times better than others in similar categories and grow at significantly faster rates than the overall market. Why all this profit and growth? Ultimately it comes down to human psychology. A Global Purpose Drives The People Who Drive Your Business From a social science perspective, the effect of purpose on both employees and customers is not surprising. When people see their work as serving the greater good they are more likely to be engaged, committed, and productive. A sense of global purpose has been found to be one of the most powerful psychological motivators for both employees and customers. Ultimately, people want to believe in something that's bigger than themselves. People and organizations who believe in and prove their reason for existence inspire more loyal people to join their movements and invest in their products. In numerous studies, like those published by the firm Imperative, a sense of purpose is ranked as the most significant factor in job satisfaction and quadruples the likelihood of being engaged at work. And by 2025 nearly 70% of consumers and employees will identify with the Millennial generation. A recent survey by Deloitte found that an overwhelming 75% of Millennials indicated that they were more likely to do business with or work for a company that exists to better society. And customers want to be a part of changing the world, too. People are psychologically drawn to products and services that align with their beliefs about the way the world should and can be. Simon Sinek, in his 2009 viral Ted Talk implored, "People don't buy what you do. They buy why you do it." He is proving to be right. Case Study: A Luxury Fragrance Company That Empowers Farmers In Emerging Countries Serge Majoullier, Perfumer and David Morenon, Deputy Purchasing Manager in Nepal. Image Credit: Gone Adventurin & MANE MANE Flavor and Fragrance Manufacturer offers an inspiring case of how a global purpose can transform a business. MANE is one of the world's leading flavors and fragrances companies and produces flavors, fragrances, and ingredients for beverages, biscuits, confectionery, dairy products, and savory food applications. What does it mean for a flavor and fragrances manufacturer to drive profit through a global purpose? For MANE it means creating sustainable sourcing in its markets in emerging countries. MANE realized that 70% of worldwide raw materials are produced by smallholder farmers, yet millions of those farmers remain impoverished. Poverty among smallholder farmers is one of the most pressing social issues in developing countries and when these farmers are not empowered, they cannot grow enough high quality raw materials. Additionally, MANE's clients have started to put pressure on the company to create transparent value chains. Poverty among smallholder farmers constitutes one of the world's most pressing social issues. Now it's at the core of MANE's purpose too. In 2015, MANE created sustainable sourcing initiatives in Nepal to develop a market of a new species of pepper called Timur. The challenge was to partner with grassroots and local NGOs to empower farmers on the ground through workshops and trainings to grow better quality raw materials. The ultimate goal was to help remote pepper farmers secure a more sustainable living. Beyond simply having a business goal, MANE decided to immerse its employees in this global purpose and use storytelling to involve its stakeholders in this global purpose. The results were transformational. Not only did the project create an entire market for the Timur product and help the economy of Nepal to grow, MANE won the first communications price at the World Perfumery Congress garnering hundreds of thousands dollars worth of free public relations promotion. Watch MANE's inspiring sustainable sourcing initiatives here. MANE proves that filling a societal need and profit are not mutually exclusive. In fact, purpose can drive profit. 3 Ways to Discover and Enact Your Company's Global Purpose In our fast-paced and results-oriented marketplace, many company leaders simply don't think they have the time or resources to invest in purpose - or they don't conceptualize their industry as particularly "world-saving." But every company does and can have a compelling global reason for existence. The key for leaders is to begin discovering this purpose, strategizing around it, and then telling the story to its stakeholders. Here are three powerful ways to start now: 1. Identify your company's problem. What is the world problem that your company exists to solve? This problem can become your purpose. A great place to start is by reading the United Nations Sustainable Development Goals (SDGs) report and and facilitating discussion in your organization around the 17 identified key topics below. Not only do the SDGs provide a great framework for finding a compelling global purpose but they are also a great and credible way to communicate about it. They aim to inspire business leaders to think deeper into the many issues that plague the world; from hunger to gender inequality. "The seventeen Sustainable Development Goals (SDGs) are our shared vision of humanity and a social contract between the world's leaders and the people. They are a to-do list for people and planet, and a blueprint for success." said Ban Ki-moon, the former UN Secretary-General. Image Credit: United Nations 2. Authentically communicate your global purpose. Human beings rely on stories to make sense of our world and so do your customers and employees. Telling the story of how your company helps to deliver your global purpose can generate stakeholders' emotional commitment to your company and brand. Below are a few tips to start: Show the people who make your products and where they make them Take stakeholders and employees on journeys to see the origins of your materials Have customers themselves tell stories about how your company is changing the world Consistently strategize: Which of our products or services can make the world a better place; and how is that a business opportunity? The Lipton tea brand offers a powerful example of engaging stakeholders in their purpose. Lipton decided to intentionally strategize about what they wanted their consumers thinking about when they drank their morning tea. Lipton wanted them to feel that their tea was more than tea - it was serving the world. By telling the story of the tea farmers working in beautiful sustainable plantations and connecting them to the partnership of Lipton with one of the most impactful forest NGOs, Rainforest Alliance, Lipton gives consumers a world-changing purpose. Learn more about Lipton's global purpose here. 3. Start seeing social and environmental issues as business opportunities. Just as the MANE company example shows us, global needs can also be business opportunities. For example, let's imagine you are a leader making equipment for optometrists and surgeons, as well as contact lenses. Your bigger purpose is to eradicate avoidable blindness because you know there are opportunities. Four billion people in the world need glasses but only 2.5 billion of people have glasses, so you can tap into a massive market of 1.5 billion people Another example comes from the food industry and answers the question: What is the future of food? For Caleb Harper, director of the Open Agriculture Initiative at (MIT), the future of food is not a disaster as many pundits would have us believe, it's a business opportunity - especially for tech companies. Caleb wants to change the food system by connecting growers with technology. Caleb said, "With the right tech, urban agriculture could turn basements, warehouses, walls and skyscrapers into farms." Re-framing critical issues or "problems" as opportunities can be powerful. Your company's purpose is already out there in the world. Identifying it and building your company around it pays. What is your cause? Why does your company exist? How can tackling social and environmental issues grow your business - and save the world? Gone Adventurin is a social enterprise - based in Singapore and operating across Asia - that helps companies to grow through social and environmental impact. The organisation has been tackling different issues from waste recycling for consumer goods companies to sustainable supply chain or water scarcity. The team has been working with many different companies such as Unilever, Procter & Gamble or Danone. Zach Mercurio is a consultant, speaker, and educator who builds purposeful organizations and empowers purposeful people to better our world. Learn more here. Featured Image Credit: Gone Adventurin -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

21 декабря 2016, 19:13

FACT SHEET: Obama Administration Announces New Manufacturing USA Institute, Third Institute Awarded in Three Weeks

The Advanced Regenerative Manufacturing Institute (ARMI), Inc., headquartered in Manchester, NH, brings nearly $300 million in public-private investment from leading manufacturers and universities to develop the cells, tissues, and organs that may one day restore form and function to wounded warriors and civilians. Today, the Department of Defense is awarding the new Advanced Tissue Biofabrication Manufacturing USA institute, which brings together a consortium of 87 partners from across industry, academia, and government to develop the manufacturing technologies for life-saving cells, tissues, and organs. The winning coalition, led by ARMI, Inc. and headquartered in Manchester, NH will develop next-generation manufacturing techniques for repairing and replacing cells and tissues, which may one day lead to the ability to manufacture new skin for soldiers scarred from combat or develop organ-preserving technologies to benefit Americans waiting for an organ transplant.  The Advanced Regenerative Manufacturing Institute being announced today is the twelfth manufacturing hub awarded by the Obama Administration, and follows on the heels of two other hubs announced in the last two weeks—the National Institute for Innovation in Manufacturing Biopharmaceuticals, the first open-topic institute and the first institute awarded by the Department of Commerce, headquartered in Newark, DE; and the Rapid Advancement in Process Intensification Deployment Institute, awarded by the Department of Energy, headquartered in New York, NY. Today at the White House, Under Secretary of Defense for Acquisition, Technology and Logistics Frank Kendall will announce the winning consortium before an audience of stakeholders from industry, academia, and government, including senior leaders from the White House, Department of Commerce, Department of Energy, and representatives from many of the existing Manufacturing USA institutes. In the four years since its establishment, Manufacturing USA has grown from one institute with 65 members to a network of now 12 institutes with nearly 1,000 members.  The institutes are already attracting new business investment to their regions, developing the cutting-edge technologies to drive American leadership, and training the workforce that will apply new skills to our manufacturing sector.  Across the Manufacturing USA institutes, the Federal government has committed over $850 million, which has been matched by more than $1.8 billion in non-Federal investment. Today’s progress builds on important bipartisan action from Congress, which in 2015 passed the bipartisan Revitalize American Manufacturing and Innovation to formally authorize the program, proving that strengthening American manufacturing is a goal on which we can all agree. After a decade of decline from 2000 to 2009, the U.S. manufacturing sector has added over 800,000 jobs since early 2010.  Despite recent headwinds, the foundation for U.S. manufacturing is stronger than it has been in decades. Just this year, a new report on global manufacturing competitiveness found that manufacturing executives view the United States as the best location in the world for manufacturing in the years ahead.  The New Manufacturing USA Institute Awards Manufacturing USA connects people, ideas, and technology to solve industry-relevant advanced manufacturing challenges, enhancing industrial competitiveness and economic growth and strengthening our national security. Each manufacturing institute is designed to build U.S. leadership and regional excellence in critical emerging manufacturing technologies by bridging the gap between early research and product development; bringing together companies, universities, and other academic and training institutions, and Federal agencies to co-invest in key technology areas that can encourage investment and production in the United States while serving as a ‘teaching factory’ for workers, small businesses, and entrepreneurs looking to develop new skills or prototype new products and processes. Repairing and replacing cells, tissues, and organs. Announced today, the Advanced Regenerative Manufacturing Institute is poised to develop next-generation manufacturing techniques for repairing and replacing cells and tissues, which may one day lead to the ability to manufacture new skin for soldiers scarred from combat or develop organ-preserving technologies to benefit Americans stuck on organ transplant waiting lists. Headquartered in Manchester, NH, ARMI will focus on solving the cross-cutting manufacturing challenges that stand in the way of producing new synthetic tissues and organs—such as improving the availability, reproducibility, accessibility, and standardization of manufacturing materials, technologies, and processes to create tissue and organ products. ARMI will convene leaders from a multitude of disciplines, from cell biology and bioengineering to materials science and computer modeling. The partners will work to develop high-throughput culture and 3D biofabication techniques to non-invasive, real-time testing and sensing to measure the viability of engineered tissue constructs. Industry Partners: Abbott, Autodesk, Becton Dickinson, Celularity, DEKA Research & Development, GenCure, Humacyte, Lonza, Medtronic, Rockwell Automation, and United Therapeutics Government and non-profit organizations: FIRST, the State of New Hampshire, and Manufacturing Extension Partnerships in multiple states Universities and Other Schools: Arizona State University, Boston University, Cedars-Sinai Medical Center, Dartmouth College, Harvard University, Massachusetts Institute of Technology, Rutgers, Stanford University, the University of Florida, the University of Minnesota, the University of New Hampshire, Worcester Polytechnic Institute, and Yale University Life-saving bio-therapies. On December 16, Commerce Secretary Penny Pritzker announced the winner of the Department of Commerce’s first institute and the first open-topic institute competition: the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). NIIBML will be led by USA Bio Consortium, a team of more than 150 partners representing all of the elements required to make biopharmaceutical drugs—from the equipment makers and suppliers of raw materials, to the companies developing new treatments and readying them for clinical trials and regulatory approval, to the clinics treating patients. NIIMBL will work to accelerate the transition of disease-treating biopharmaceuticals from the lab to the market, with the aim to make these live-saving therapies more accessible to patients. NIIMBL will also help rapidly scale up manufacture of these advanced treatments to respond to pandemics and other biological threats, address drug shortages resulting from issues in manufacturing, and support precision medicine by exploring new processes and equipment to allow the cost-effective manufacture of single-batch biopharmaceutical exactly matched to an individual’s genetics or disease. Read more here, and how NIIMBL’s efforts will complement ARMI’s efforts here. Companies and Non-Profit Organizations: Agilent Technologies, AIChE, Air Liquide, Altimmune, Amgen, Amgen Foundation, Artemis Biosystems, Association of University Research Parks, ASTM, BioFactura, Biogen, BioHealth Innovation, Biologics Modular, BioPhorum Operations Group, bioVolutions, BMC Corp, Boehringer Ingelheim Fremont, California Manufacturing Technology Consulting, Celgene Corp, Charles River Laboratories, ChromaTan, Cimetrics, Colorado BioScience Association, Commissioning Agents, Inc, Connecting Connecticut's Science Community, Continuus Pharma, Corning Life Sciences, DelawareBio, DEMEP, DVIRC, Eli Lilly Research Labs, EMD Serono, FiberCell Systems, FloDesign Sonics, Fraunhofer CMB, Fraunhofer CESE, GBSI, GE Healthcare Life Sciences, Georgia Bio, Georgia Tech MEP, Grifols S.A., IBM, ILC Dover, ImmunoGen, Indiana Health Industry Forum, Institute for BioScience & Biotechnology Research, Intellia Therapeutics, IOWABio, Janssen Pharma, Juno Therapeutics, Kentucky Life Sciences Council, LakePharma, Lewa Process Technologies, Lonza Biologics Inc., Manex, MANTEC, MassBio, MassMep, MD MEP, MedImmune, MEPOL, MilliporeSigma, National Institute for Pharmaceutical Technology and Education, NC Bio, NC MEP, NEPIRC, NewYorkBIO, North Carolina Biotechnology Center, Novartis, Novo Nordisk, NYDSTI, Orochem, Pall Corp, Parental Drug Association, PBS Biotech, Pennsylvania Bio, Pfizer, Pharma Matrix, Pharyx Inc., Protein Sciences Corp, Purdue MEP, Regeneron Pharma, RepliGen, Rooster Bio, Sanofi Pasteur, SC MEP, Shire, Southwest Research Institute, SoyMeds, Stratosphere, Sudhin Biopharma, Tech Council of MD, Terumo BCT, THBI, Thrive Bioscience, University City Science Center, Unum Therapeutics, USP, Vericel Corp, Voyager Therapeutics, VWR, Waters Universities, Colleges and Other Schools: Bio-Link (City College of San Francisco), Carnegie Mellon University, Clemson University, Delaware State University, Delaware Technical Community College, East Carolina University, Georgia Institute of Technology, Harvard University, IVY Tech Community College, Johns Hopkins University, MARBIONC: Marine Biotechnology in NC (UNC Wilmington), Massachusetts Institute of Technology, Memorial Sloan Kettering, MiraCosta College District, Montgomery College, Northeast Biomanufacturing Center and Collaborative, North Carolina Central University, North Carolina Community College's BioNetwork System, North Carolina State University, Pennsylvania State University, Purdue University, Quincy College, Rensselaer Polytechnic Institute, Solano Community College, The University of Texas at Austin, Tulane University, University of California Berkeley, University of Colorado Boulder, University of Connecticut, University of Delaware, University of Georgia, University of Iowa, University of Kansas, University of Kentucky, University of Maryland, University of Massachusetts, University of Minnesota, University of North Carolina Chapel Hill, University of North Carolina Charlotte, University of Pennsylvania, University of Wisconsin State Government and Regional Organizations: Commonwealth of Pennsylvania, Massachusetts Life Sciences Center, State of Delaware, State of Maryland, State of Minnesota, State of North Carolina States: Arizona, California, Colorado, Connecticut, Delaware, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, New Hampshire, New Jersey, New York, North Carolina, Pennsylvania, South Carolina, Texas, Washington, Washington D.C., Wisconsin Ultra-efficient chemical manufacturing. On December 9, the Acting Assistant Secretary for Energy Efficiency and Renewable Energy in the Department of Energy David Friedman announced that the American Institute of Chemical Engineers will lead the Rapid Advancement in Process Intensification Deployment (RAPID) Institute. With over 130 partners from universities, companies, local and state organizations, and other Manufacturing USA institutes, the RAPID institute will work to develop new modular technologies to enable customized factories, local manufacturing in remote locations, and greater utilization of U.S. raw materials for manufacturing, while training future U.S. workers in these advanced fields. The RAPID institute will work to advance manufacturing processes used for making chemicals, refining fuels, and producing other everyday products used across the U.S. economy. By optimizing manufacturing at the molecular level, technologies developed by this institute will aim to save energy with every chemical reaction. In addition to improving energy efficiency, these technologies can lead to big savings on the manufacturing floor, such as cutting operating costs, waste, and equipment footprint. In the chemical industry alone, these technologies have the potential to save more than $9 billion in process costs annually. For example, by simplifying and shrinking the physical space needed for manufacturing, this approach may enable natural gas refining directly at the wellhead, saving up to half of the energy lost in the ethylene cracking process today. Read more here. Initial partners include: Industry partners: Alloy Surfaces, Arkema, AspenTech, ATI Specialty Alloys, Automation Solutions, Avatar Sustainables, Ayers Group, BASF, BgtL, Biodico, Cantrell Capital, CB&I, Cermatec, CF Technologies, Compact Membrane Systems, Convergent Catalysis, Corning, Cummins, Domtar, Dow, Dow Water Solutions, DuPont, Earth Energy Renewables, Eastman Chemical, Easy Energy Systems, EcoCatalytic Technologies, Emerson Process Management, Enginuity Worldwide, Environmental & Fuel Research LLC, Environmental Engineering Solutions, ExxonMobil, Fluor, Franklin International, Full Cycle Bioplastics, FutureCeuticals, GE Water and Process Technologies, Greenway Energy, H Quest Vanguard, i3D MFG, Intellectual Assets, IntraMicron Inc., Italmatch Chemicals, Kore Infrastructure, Lubrizol, Managed Technology Solutions Group, Matric, NatureWorks, NuScale Power, Onboard Dynamics, Pall Corp., Paul Weaver Construction Equipment, Petron Scientech, Pioneer Tank & Vessel, Portland General Electric, Praxair, Process Systems Enterprise, Reliance Industries, RnD Consulting, Roeslein Alternative Energy, Saint Gobain NorPro, Secat Inc., Shell, Sigma Innova, Solar Fuels & Chemicals, Solvay, Southern Company, Strategic Analysis, United Technologies Research Center, Vacuum Process Engineering, vanZoen, Waste Resource Recovery, Xcel Energy, Zaiput Flow, Zeachem, Zeton Local and State Organizations: Alabama Department of Commerce, Iowa Economic Development, Iowa Energy Center, State of Oregon, Oregon Manufacturing Extension Partnership, South Carolina Department of Commerce, South Carolina Manufacturing Extension Partnership Academic Partners and Research Institutions: Auburn University, Carnegie Mellon University, Case Western University, Clemson University, Drexel University, Georgia Institute of Technology, Iowa State University, Manhattan College, Michigan State University, Massachusetts Institute of Technology, North Carolina State University, Oregon State University, Rutgers University, State University of New York, Texas A&M, Texas Tech University, University of Alabama, University of Arizona, University of California at Los Angeles, University of Delaware, University of Idaho, University of Illinois, University of Kentucky, University of Louisville, University of Michigan, University of Minnesota, University of North Dakota, University of Pittsburgh, University of South Carolina, University of Southern California, University of Texas, University of Wyoming, Worchester Polytechnic Institute, West Virginia University.  Not for Profit and Independent Associations: American Chemistry Council, American Chemical Society, Agenda 2020, Clean Energy Smart Manufacturing Institute, Digital Manufacturing and Design Innovation Institute, Gas Technology Institute, Glass Manufacturers Industry Council, Institute for Advanced Composites Manufacturing Innovation, National Society of Black Engineers, Research Triangle Institute, Society of Chemical Manufacturing and Affiliates, Southern Research Institute.  Laboratories: The Ames Laboratory, Idaho National Laboratory, Lawrence Livermore National Laboratory, National Energy Technology Laboratory, Oak Ridge National Laboratory, Pacific Northwest National Laboratory, Savannah River National Laboratory, The Forest Products Laboratory (U.S. Forest Service), The National Risk Management Laboratory (EPA). Ongoing Institute Competitions In addition to the three institutes announced since December 9, other Manufacturing USA institute topics are now under competition in the areas of: Sustainable materials manufacturing. In collaboration with the Department of Energy, the winner of the competition for the Reducing Embodied Energy and Decreasing Emissions (REMADE) in Materials Manufacturing Institute will focus on reducing the total lifetime use of energy in manufactured materials by developing new cradle-to-cradle technologies for the reuse, recycling, and remanufacturing of manmade materials. U.S. manufacturing consumes nearly a third of the nation’s total energy use annually, with much of that energy embodied in the physical products made in manufacturing. New technologies to better repurpose these materials could save U.S. manufacturers and the nation up to 1.6 quadrillion BTU of energy annually, equivalent to 280 million barrels of oil, or a month’s worth of domestic oil imports. Read more here. Collaborative robotics. Together with the Department of Defense, the winner of the competition for the Robots in Manufacturing Environments Manufacturing USA Institute will focus on building U.S. leadership in smart collaborative robotics, where advanced robots work alongside humans seamlessly, safely, and intuitively to do the heavy lifting on an assembly line or handleintricate or dangerous tasks with precision. People collaborating with robots has the potential to change a broad swath of manufacturing sectors, from defense and space to automotive and health, enabling the reliable and efficient production of high-quality, customized products. Read more here. Industry-proposed topic. Leveraging authorities from the Revitalizing American Manufacturing and Innovation Act with broad bipartisan support in Congress, the Department of Commerce has launched the first “open topic” institute competition. This competition is open to any topic proposed by industry not already addressed by a manufacturing innovation institute. In addition to NIIMBL, which is awarded using FY2016 funds, additional institutes may be awarded from this competition, subject to the availability of additional funds. The open topic competition design allows industry to propose technology areas seen as critical by leading manufacturers to the competitiveness of U.S. manufacturing. Read more here. Early Successes from Manufacturing USA Together, the Manufacturing USA institutes are already enhancing U.S. competitiveness in advanced manufacturing—from helping Youngstown, OH attract over $90 million in new manufacturing investments to its region and train 14,000 workers in the fundamentals of 3D printing for businesses, to supporting companies like X-FAB in Lubbock, TX upgrade to next-generation power semiconductors and sustain hundreds of jobs. These public-private partnerships are bringing value to their members and regions by providing: Technological Innovation: By accelerating the transition from design to Made in USA, the institutes are developing emerging manufacturing technologies—for example, America Makes, the National Additive Manufacturing Innovation Institute in Youngstown, OH enabled one of its founding members, Oxford Performance Materials, Inc., to become the first company to receive clearance from the U.S. Food & Drug Administration to manufacture 3D-printed polymer implants for use in surgical procedures in the United States. Collaborative Constituencies: The institutes align pre-competitive industry priorities by combining the efforts of manufacturers across geographies and supply chains—for example, the American Institute for Manufacturing Integrated Photonics (AIM Photonics), the Integrated Photonics Institute in Rochester, NY, has members on both coasts that, collectively, comprise  the entire supply chain for integrated photonics, from microfabrication processing training and circuit design centers in Massachusetts; to wafer foundry, packaging, and assembly centers in New York; to integrated photonic device manufacturers in California. Leveraged Investments: For companies, institute membership provides access to unique equipment and capabilities that are too costly for any one company to undertake—for example, Advanced Functional Fabrics of America (AFFOA), the Revolutionary Fibers and Textiles institute in Cambridge, MA, is standing up a distributed, on-demand foundry to rapidly identify domestic manufacturing pathways within its membership to accelerate the design-to-product process. Networked Expertise: Manufacturing USA is at its best when the institutes are working together— for example, to create a talent pipeline of multi-skilled manufacturing technicians. This cross-institute effort is designed to match talent demands from industry members with the best content from academia members, define promising career pathways, and align workforce investment resources across municipalities, states, and regions. Customized Training: Institutes act as "teaching factories," providing hands-on factory workforce training for the relevant technology-- for example, NC State, the lead for Power America, has created a Master’s of Science concentration focused on wide band gap semiconductor power electronics. More than 200 graduate students at NC State and member universities of Power America are now studying power electronics each year. As a result, over 225 freshman engineering students have been introduced to wide band gap semiconductors, building a talent pipeline of future graduates. Business Opportunities: By developing national expertise across their supply chains, the institutes are creating new reasons for companies to locate jobs and investment in their regions and the United States—for example, Leisure Pools, a polymer composite pool manufacturer originally from Australia, has relocated its facilities to be near the Institute for Advanced Composites Manufacturing Innovation (IACMI) in Knoxville, TN, as Leisure Pool moves into new areas to become an advanced manufacturer of carbon fiber composite material products and adds up to 1,000 jobs in Knoxville over the next decade. Innovation Ecosystems: The institutes are creating trusted environments, knitting together technical expertise across supply chains to craft new business opportunities—for example, the Digital Manufacturing and Design Innovation Institute (DMDII) in Chicago, IL is providing space within its facilities for start-ups developing their business, facilitating relationships between young companies and large industrial members through collaborative projects. Rejuvenated Neighborhoods: By anchoring regional manufacturing competitiveness, the institutes are breathing new life into the manufacturing regions where they are located—for example, Lightweight Innovations for Tomorrow (LIFT), the lightweight and modern metals manufacturing institute in Detroit, MI, has transformed a former factory that was abandoned during the wave of offshoring in the early 2000s, rejuvenating one of Detroit’s oldest neighborhoods. To learn more about the open competitions for these next manufacturing innovation institutes, please visit Manufacturing.gov. In addition to today’s announcement, the established manufacturing innovation institutes are: America Makes, the National Additive Manufacturing Innovation Institute (Youngstown, OH) Digital Manufacturing and Design Innovation Institute (Chicago, IL) Lightweight Innovations for Tomorrow (Detroit, MI) Power America (Raleigh, NC) Institute for Advanced Composites Manufacturing Innovation (Knoxville, TN) American Institute for Manufacturing Integrated Photonics (Rochester, NY) Next Flex, the Flexible Hybrid Electronics Manufacturing Innovation Institute (San Jose, CA) Advanced Functional Fabrics of America (Cambridge, MA) Smart Manufacturing Innovation Institute (Los Angeles, CA) Rapid Advancement in Process Intensification Deployment (New York, NY) National Institute for Innovation in Manufacturing Biopharmaceuticals (Newark, DE)

21 декабря 2016, 15:21

Fluor to Build Novo Nordisk's $2B API Manufacturing Unit

Fluor Corporation (FLR) recently announced that it has clinched a major engineering, procurement, construction and construction management contract from Denmark-based pharmaceutical behemoth, Novo Nordisk.

Выбор редакции
19 декабря 2016, 15:54

Why American Funds New World A Fund (NEWFX) Worth Another Look?

American Funds New World A Fund (NEWFX) seeks to provide long-term growth of capital by investing in stocks and bonds.

16 декабря 2016, 14:58

Lilly Stock Surges on Robust 2017 View; Launches Basaglar

Eli Lilly and Company (LLY) issued a better-than-expected financial guidance for 2017, alleviating investor concern to a large extent.

14 декабря 2016, 16:09

Eli Lilly (LLY) to Offer Discount on Insulin from January

Eli Lilly (LLY) announced that the company will offer access to its insulin products at discounted prices, starting Jan 2017.